Androgen deprivation therapy prevents bladder cancer recurrence
about
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and ProgressionSteroid Hormone Receptor Signals as Prognosticators for Urothelial TumorConditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in MiceIs there a gender effect in bladder cancer? A population-based study of practice and outcomesThe effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancerTumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signalsELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progressionSex differences in the MB49 syngeneic, murine model of bladder cancer.Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrenceAndrogen receptor activity modulates responses to cisplatin treatment in bladder cancerAndrogen Receptor Signaling in Bladder Cancer.High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.Gender differences in incidence and outcomes of urothelial and kidney cancer.Concomitant bladder cancer and prostate cancer: challenges and controversies.Androgen receptor activation: a prospective therapeutic target for bladder cancer?Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinomaExpression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy.Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.Bladder cancer.
P2860
Q26744754-457FB966-EFBF-4119-A814-6D65F71D3FE3Q26771960-32C4979E-D403-49F0-BF78-BE871C3C81CAQ28550059-1DD211E2-64AF-4319-8A7D-9BDF886D0FB6Q35956254-B0C5647A-2FEC-43E3-A171-ACB1F573EC9AQ36261347-8EAC1F51-A6B6-42CE-9D55-F9F52DA15FA9Q36413361-7739AC86-C1AF-4D6C-97B7-1FB98E9C78ECQ36557452-BCD81FA1-7A83-4891-B43C-742648E178DBQ36695620-C69FD126-2EE3-4307-9177-8375084166EBQ37046554-8FB1C7E4-5603-4C2F-A97A-084BB930EE38Q37580192-6AE24E6E-373E-4445-85B3-BF2BE883653EQ37676080-08E9E0F2-C34A-4B27-B9C3-C002CAF5D647Q37723023-F32CC915-85B8-471A-9103-EB03EF7EB995Q38599201-7C929240-6155-4D34-B976-155992EAD61CQ38622335-92BB0583-65AD-47F1-961D-45201BF35634Q39033724-D4976240-8700-46C6-8352-70F4902DEC95Q41279969-349D9322-25D7-4BB8-AEDA-C82105F9BCDFQ41728557-53F0F234-3BF2-4EBA-9A47-2B4EEC7DE712Q41995379-2068A263-26A6-46CF-8129-AB231A26E61FQ46808504-037CE1F2-892C-4B87-B0A9-DB85CB02625AQ52810295-105FCBED-E485-41D7-9756-B166F187A4FD
P2860
Androgen deprivation therapy prevents bladder cancer recurrence
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Androgen deprivation therapy prevents bladder cancer recurrence
@ast
Androgen deprivation therapy prevents bladder cancer recurrence
@en
type
label
Androgen deprivation therapy prevents bladder cancer recurrence
@ast
Androgen deprivation therapy prevents bladder cancer recurrence
@en
prefLabel
Androgen deprivation therapy prevents bladder cancer recurrence
@ast
Androgen deprivation therapy prevents bladder cancer recurrence
@en
P2093
P2860
P356
P1433
P1476
Androgen deprivation therapy prevents bladder cancer recurrence
@en
P2093
Futoshi Tsuchiya
Hiroji Uemura
Ichiro Ikeda
Kazuki Kobayashi
Kazumi Noguchi
Kazuo Kitami
Kimio Chiba
Kiyoshi Fujinami
Koichi Udagawa
Koji Izumi
P2860
P304
12665-12674
P356
10.18632/ONCOTARGET.2851
P407
P577
2014-12-01T00:00:00Z